We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR, GALEN FINALIZE LOESTRIN PURCHASE AGREEMENT
BARR, GALEN FINALIZE LOESTRIN PURCHASE AGREEMENT
April 6, 2004
Galen Holdings and Barr Pharmaceuticals have finalized deals that give Barr exclusive rights to Galen’s Loestrin oral contraceptive products and Galen the option to market Barr’s generic version of its own oral contraceptive Ovcon 35.